Ryntexia Pharma Private Limited

Ryntexia Pharma Private Limited - pharma in Kanpur, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U74999UP2018PTC110816 Incorporated 03 December 2018 ROC Uttar Pradesh HQ Kanpur, Uttar Pradesh, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2022
₹18.88 Lakh
▲ 184% YoY
Net profit · FY 2022
₹10,595
Net margin 0.6%
EBITDA · FY 2022
-₹13.85 Lakh
EBITDA margin -73.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹6.28 Lakh
No open charges
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings

About Ryntexia Pharma Private Limited

Data last updated:

Ryntexia Pharma Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 December 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2018PTC110816. Its GSTIN is 09AAJCR2786E1Z1 (Uttar Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Udaya Singh Tomar and Neelam Singh Tomar.

Its last annual general meeting (AGM) was held on 09 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mig – 173/Mig Block Tatya Tope Nagar Phase II, Kanpur, Uttar Pradesh, India – 208022.

As per the financials filed for FY 2022, the company reported a revenue of ₹18.88 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹10,595 (net margin 0.6%) and EBITDA of -₹13.85 Lakh (EBITDA margin -73.4%).

As per MCA filings, the company has satisfied charges of ₹6.28 Lakh on record.

Ryntexia Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-43-0013923).

Company details

CIN U74999UP2018PTC110816
Registration Number 110816
Incorporation Date 03 December 2018
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 09 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-43-0013923

Recognitions & Rankings of Ryntexia Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-UP-43-0013923

Contact details

Ryntexia Pharma Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Mig – 173/Mig Block Tatya Tope Nagar Phase II, Kanpur, Uttar Pradesh, India – 208022
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Ryntexia Pharma Private Limited, buy the company report.

Comprehensive company report
Ryntexia Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ryntexia Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Ryntexia Pharma Private Limited, buy the company report.

Financials of Ryntexia Pharma Private Limited

FY 2025 filings available

Ryntexia Pharma Private Limited reported revenue of ₹18.88 Lakh (up 184% YoY) for FY 2022.

Revenue · FY 2022
₹18.88 Lakh ▲ 184%
Net profit · FY 2022
₹10,595 margin 0.6%
EBITDA · FY 2022
-₹13.85 Lakh margin -73.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 184%

Revenue rose 184% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹18.88 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹13.85 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹10,595
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-73.4%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ryntexia Pharma Private Limited, buy the company report.

Board of directors of Ryntexia Pharma Private Limited

Ryntexia Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Udaya Singh TomarDirector03 Dec 20187 Years 10 MonthsCurrent
Neelam Singh TomarDirector03 Dec 20187 Years 10 MonthsCurrent

Auditor

Ryntexia Pharma Private Limited is audited by SINGH SHIVAM & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
SINGH SHIVAM & COFY 2019023093C

Shareholding

The shareholding of Ryntexia Pharma Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Ryntexia Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹6.28 Lakh
Breakdown by lending institutions
Indian Overseas Bank₹0.06 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
25 Jun 2021100490443Indian Overseas Bank₹4.5 LakhSatisfied
14 Aug 2020100375034Indian Overseas Bank₹28,000Satisfied
30 Jul 2019100283829Indian Overseas Bank₹1.5 LakhSatisfied

To see the full charge records of Ryntexia Pharma Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ryntexia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ryntexia Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAJCR2786E1Z1Uttar PradeshActive02 Apr 2019

To see the full GST registrations and return filing status of Ryntexia Pharma Private Limited, buy the company report.

Recent activity

Ryntexia Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Neelam Singh Tomar was appointed as Director on 03 Dec 2018.

AGM
Ryntexia Pharma Private Limited last Annual general meeting of members was held on 09 Sep 2025 as per latest MCA records.
Filing
Ryntexia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Charges
A charge registered on 25 Jun 2021 via Charge ID 100490443 with Indian Overseas Bank was fully satisfied on 17 Jan 2024.
Charges
A charge registered on 14 Aug 2020 via Charge ID 100375034 with Indian Overseas Bank was fully satisfied on 17 Jan 2024.
Charges
A charge with Indian Overseas Bank of Rs. 4.50 Lakh registered on 25 Jun 2021 with Charge ID 100490443 was modified on 21 Nov 2022.
Charges
A charge with Indian Overseas Bank amounted to Rs. 4.50 Lakh with Charge ID 100490443 was registered on 25 Jun 2021.
Charges
A charge registered on 30 Jul 2019 via Charge ID 100283829 with Indian Overseas Bank was fully satisfied on 31 Mar 2021.
Charges
A charge with Indian Overseas Bank amounted to Rs. 0.28 Lakh with Charge ID 100375034 was registered on 14 Aug 2020.
Charges
A charge with Indian Overseas Bank amounted to Rs. 1.50 Lakh with Charge ID 100283829 was registered on 30 Jul 2019.
Appointed
Neelam Singh Tomar was appointed as Director.
Appointed
Udaya Singh Tomar was appointed as Director.
Incorporation
03 Dec 2018
Ryntexia Pharma Private Limited was registered on 03 Dec 2018 with Roc Uttar Pradesh I & aged 7 years 10 months as per MCA records.

Frequently asked questions

Ryntexia Pharma is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 December 2018 (8+ years old) and is registered under CIN U74999UP2018PTC110816.

Ryntexia Pharma has 2 current directors:

The latest financial statements of Ryntexia Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 09 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Ryntexia Pharma is 09AAJCR2786E1Z1, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Ryntexia Pharma is U74999UP2018PTC110816. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ryntexia Pharma was incorporated on 03 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

Neelam Singh Tomar was appointed as Director on 03 Dec 2018. Udaya Singh Tomar was appointed as Director on 03 Dec 2018.

Yes, Ryntexia Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-43-0013923).

The registered office of Ryntexia Pharma is at Mig – 173Mig Block Tatya Tope Nagar Phase II, Kanpur, Uttar Pradesh, India – 208022.

Ryntexia Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.